Log In
Print this Print this

Intranasal interferon (IFN) beta

  Manage Alerts
Collapse Summary General Information
Company Aegis Therapeutics LLC
DescriptionIntranasal formulations of interferon (IFN) beta
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
PartnerNerveda Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today